These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25549791)

  • 1. Translational application of nano delivery systems: emerging cancer therapy.
    Chougule MB; Tan C
    AAPS PharmSciTech; 2015 Feb; 16(1):3-4. PubMed ID: 25549791
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The holistic 3M modality of drug delivery nanosystems for cancer therapy.
    Sun J; Luo C; Wang Y; He Z
    Nanoscale; 2013 Feb; 5(3):845-59. PubMed ID: 23292001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug self-delivery systems for cancer therapy.
    Qin SY; Zhang AQ; Cheng SX; Rong L; Zhang XZ
    Biomaterials; 2017 Jan; 112():234-247. PubMed ID: 27768976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    Su CW; Chiang CS; Li WM; Hu SH; Chen SY
    Nanomedicine (Lond); 2014 Jul; 9(10):1499-515. PubMed ID: 25253498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-sized drug delivery systems for lymphatic delivery.
    Cho HY; Lee YB
    J Nanosci Nanotechnol; 2014 Jan; 14(1):868-80. PubMed ID: 24730304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Brave new world - Focus on nanomedicine.
    Alexiou C; Fadeel B
    Biochem Biophys Res Commun; 2015 Dec; 468(3):409-10. PubMed ID: 26518649
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoparticle systems reduce systemic toxicity in cancer treatment.
    Wang H; Yu J; Lu X; He X
    Nanomedicine (Lond); 2016 Jan; 11(2):103-6. PubMed ID: 26653177
    [No Abstract]   [Full Text] [Related]  

  • 9. Photosensitizing hollow nanocapsules for combination cancer therapy.
    Son KJ; Yoon HJ; Kim JH; Jang WD; Lee Y; Koh WG
    Angew Chem Int Ed Engl; 2011 Dec; 50(50):11968-71. PubMed ID: 22006833
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
    Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D
    Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Nanomaterials for Drug Delivery and Cancer Therapy.
    Chakrabarti M; Kiseleva R; Vertegel A; Ray SK
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5501-11. PubMed ID: 26369109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of liposomal technologies for delivery of platinum analogs in oncology.
    Liu D; He C; Wang AZ; Lin W
    Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Multiforme and Lipid Nanocapsules: A Review.
    Aparicio-Blanco J; Torres-Suárez AI
    J Biomed Nanotechnol; 2015 Aug; 11(8):1283-311. PubMed ID: 26295134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
    Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for the treatment of triple-negative breast cancer.
    Kutty RV; Wei Leong DT; Feng SS
    Nanomedicine (Lond); 2014 Apr; 9(5):561-4. PubMed ID: 24827837
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophages associated with tumors as potential targets and therapeutic intermediates.
    Vinogradov S; Warren G; Wei X
    Nanomedicine (Lond); 2014 Apr; 9(5):695-707. PubMed ID: 24827844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.
    Nehoff H; Parayath NN; Domanovitch L; Taurin S; Greish K
    Int J Nanomedicine; 2014; 9():2539-55. PubMed ID: 24904213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interview with Professor Jindřich Kopeček.
    Kopeček J; Stanwix H
    Nanomedicine (Lond); 2014 Apr; 9(5):577-9. PubMed ID: 24827841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
    Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
    Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.